Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 25
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Development of antifouling and bactericidal coatings for platelet storage bags using dopamine chemistry | Hadjesfandiari N, Weinhart M, Kizhakkedathu JN, Haag R, Brooks DE | 2018 | Adv Healthc Mater | View Development of antifouling and bactericidal coatings for platelet storage bags using dopamine chemistry | Researchers | New or improved product or process |
Label-free assessment of red blood cell storage lesions by deep learning | Doan M, Sebastian JA, Pinto PN, McQuin C, Goodman A, Wolkenhauer O, Parsons MJ, Acker JP, Rees P, Hennig H, Kolios MC, Carpenter AE | 2018 | bioRxiv | View Label-free assessment of red blood cell storage lesions by deep learning | Researchers | New or improved product or process |
Transfusion-associated circulatory overload prevention: a retrospective observational study of diuretic use | Lin Y, Cohen R, Armali C, Callum J, Cserti-Gazdewich C, Lieberman L, Pendergrast J | 2018 | Vox Sang | View Transfusion-associated circulatory overload prevention: a retrospective observational study of diuretic use | Researchers | Clinical research |
Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity of red blood cell products and charactersitics of extracellular vesicles. | Almizraq RJ, Norris PJ, Inglis H, Menocha S, Wirtz MR, Juffermans N, Pandey S, Spinella PC, Acker JP, Muszynski JA | 2018 | Blood Adv | View Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity of red blood cell products and charactersitics of extracellular vesicles. | Researchers | Basic research |
Albumin | Clarke G, Yan M | 2018 | Clinical Guide to Transfusion | View Albumin | Health care providers | Other |
McMaster RARE-Best practices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome | Legault K, Schunemann H, Hillis C, Yeung C, Akl EA, Carrier M, Cervera R, Crowther M, Dentali F, Erkan D, Espinosa G, Khamashta M, Meerpohl JJ, Moffat K, O'Brien S, Pengo V, Rand JH, Rodriguez Pinto I, Thom L, Iorio A | 2018 | J Thromb Haemost | View McMaster RARE-Best practices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome | Health care providers | Benchmarking and standard setting |
Designing the blood supply chain: how much, how and where? | Osorio AF, Brailsford SC, Smith HK, Blake J | 2018 | Vox Sang | View Designing the blood supply chain: how much, how and where? | Other | New or improved product or process |
Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort | Feldman BM, Rivard GE, Babyn P, Wu JKM, Steele M, Poon M-C, Card RT, Israels SJ, Laferriere N, Gill K, Chan AK, Carcao M, Klaassen RJ, Cloutier S, Price VE, Dover S, Blanchette VS | 2018 | Lancet Haematol | View Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort | Health care providers | Clinical research |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Jenkins C | 2018 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Health care providers | Benchmarking and standard setting |
The effect of unmeasurable endogenous plasma factor activity levels on factor VIII dosing in patients with severe hemophilia A | McEneny-King A, Chelle P, Iorio A, Edginton AN | 2018 | Thromb Res | View The effect of unmeasurable endogenous plasma factor activity levels on factor VIII dosing in patients with severe hemophilia A | Health care providers | Clinical research |
A Retrospective Chart Review of Transfusion Practices in the Palliative Care Unit Setting | Sirianni G, Perri G, Callum J, Gardner S, Berall A, Selby D | 2018 | Am J Hosp Palliat Care | View A Retrospective Chart Review of Transfusion Practices in the Palliative Care Unit Setting | Researchers | Clinical research |
Signalement des réactions transfusionnelles indésirables | Chargé S, Young D | 2018 | Blood.ca website | View Signalement des réactions transfusionnelles indésirables | Health care providers | Other |
Evaluation of the functional properties of cryopreserved buffy coat-derived monocytes for monocyte monolayer assay | Kipkeu BJ, Shyian ML, da Silveira Cavalcante L, Duong TT, Yeung RSM, Binnington B, Branch DR, Acker JP, Holovati JL | 2018 | Transfusion | View Evaluation of the functional properties of cryopreserved buffy coat-derived monocytes for monocyte monolayer assay | Researchers | Basic research |
Concentré de recherche: Important rôle de la GPIba, une protéine plaquettaire, dans la régulation de la production hépatique de thrombopoiétine | Ni H | 2018 | Blood.ca website | View Concentré de recherche: Important rôle de la GPIba, une protéine plaquettaire, dans la régulation de la production hépatique de thrombopoiétine | Other | Other |
Concentrates for Hemostatic Disorders and Hereditary Angioedema | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Clinical Guide to Transfusion | View Concentrates for Hemostatic Disorders and Hereditary Angioedema | Health care providers | Other |
Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31) | Turley E, McGowan EC, Hyland CA, Schoeman EM, Flower RL, Skoll A, Delisle MF, Nelson T, Clarke G, Au N | 2018 | Transfusion | View Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31) | Researchers | Clinical research |
Cancer and platelet crosstalk: opportunities and challenges for aspirin and other anti-platelet agents | Xu XR, Yousef GM, Ni H | 2018 | Blood | View Cancer and platelet crosstalk: opportunities and challenges for aspirin and other anti-platelet agents | Researchers | Basic research |
Concentré de recherche: Vers une uniformisation des politiques d'exclusion du don de sang et de plasma | Goldman M, O'Brien S, Devine D | 2018 | Blood.ca website | View Concentré de recherche: Vers une uniformisation des politiques d'exclusion du don de sang et de plasma | Researchers | Basic research |
Impact of blood manufacturing and donor characteristics on membrane water permeability and in vitro quality parameters during hypothermic storage of red blood cells | Alshalani A, Howell A, Acker JP | 2018 | Cryobiology | View Impact of blood manufacturing and donor characteristics on membrane water permeability and in vitro quality parameters during hypothermic storage of red blood cells | Researchers | Basic research |
Transfusion Safety: The Nature and Outcomes of Errors in Patient Registration | Cohen R, Ning S, Yan MTS, Callum J | 2018 | Transfus Med Rev | View Transfusion Safety: The Nature and Outcomes of Errors in Patient Registration | Health care providers | Clinical research |
Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations | Iorio A, Edginton AN, Blanchette V, Blatny J, Boban A, Cnossen M, Collins P, Croteau SE, Fischer K, Hart DP, Ito S, Korth-Bradley J, Lethagen S, Lillicrap D, Makris M, Mathôt R, Morfini M, Neufeld EJ, Spears J | 2018 | Res Pract Thromb Haem | View Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations | Health care providers | Clinical research |
Hommes gais et don de sang : Un projet à l'étude | Otis J, Caruso J | 2018 | Fugues | View Hommes gais et don de sang : Un projet à l'étude | Other | Other |
Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay | Warkentin TE, Arnold DM, Kelton JG, Sheppard J-AI, Smith JW, Nazy I | 2018 | Chest | View Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay | Researchers | Basic research |
Current practices in perioperative blood management for patients undergoing liver resection: a survey of surgeons and anesthesiologists | Bennett S, Ayoub A, Tran A, English S, Tinmouth A, McIsaac DI, Fergusson D, Martel G | 2018 | Transfusion | View Current practices in perioperative blood management for patients undergoing liver resection: a survey of surgeons and anesthesiologists | Health care providers | Clinical research |
MicroRNA-218-5p Promotes Endovascular Trophoblast Differentiation and Spiral Artery Remodeling | Brki J, Dunk C, O'Brien J, Fu G, Nadeem L, Wang Y-l, Rosman D, Salem M, Shynlova O, Yougbare I, Ni H, Lye SJ, Peng C | 2018 | Mol Ther | View MicroRNA-218-5p Promotes Endovascular Trophoblast Differentiation and Spiral Artery Remodeling | Researchers | Basic research |
Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography | Gantioqui J, Stevic I, Atkinson H, Chan AKC | 2018 | Blood Coagul Fibrinolysis | View Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography | Researchers | Basic research |
Systematic reviews do not adequately report or address missing outcome data in their analyses: a methodological survey | Kahale LA, Diab B, Brignardello-Petersen R, Agarwal A, Mustafa RA, Kwong J, Neumann I, Li L, Lopes LC, Briel M, Busse JW, Iorio A, Vandvik PO, Alexander PE, Guyatt G, Akl EA | 2018 | J Clin Epidemiol | View Systematic reviews do not adequately report or address missing outcome data in their analyses: a methodological survey | Researchers | Other |
Complications of a severe autoimmune hemolytic anemia crisis: transfusional iron overload and gangrenous cholecystitis | Menchetti I, Lin Y, Cserti-Gazdewich C, Goldstein J, Law C, Lazarus A, Callum JL | 2018 | Transfusion | View Complications of a severe autoimmune hemolytic anemia crisis: transfusional iron overload and gangrenous cholecystitis | Researchers | Clinical research |
Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia | Spaner DE, Venema R, Huang J, Norris P, Lazarus A, Wang G, Shi Y | 2018 | EBioMedicine | View Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia | Health care providers | Clinical research |
Platelet immunobiology: platelets as prey and predator | Kapur R, Semple JW | 2018 | ISBT Sci Ser | View Platelet immunobiology: platelets as prey and predator | Researchers | Basic research |
Risk of acute kidney injury in patients randomized to a restrictive versus liberal approach to red blood cell transfusion in cardiac surgery: a substudy protocol of the transfusion requirements in cardiac surgery III noninferiority trial | Garg AX, Shehata N, McGuinness S, Whitlock R, Fergusson D, Wald R, Parikh C, Bagshaw SM, Khanykin B, Gregory A, Syed S, Hare GMT, Cuerden MS, Thorpe KE, Hall J, Verma S, Roshanov PS, Sontrop JM, Mazer CD | 2018 | Can J Kidney Health Dis | View Risk of acute kidney injury in patients randomized to a restrictive versus liberal approach to red blood cell transfusion in cardiac surgery: a substudy protocol of the transfusion requirements in cardiac surgery III noninferiority trial | Researchers | Clinical research |
Adverse reactions reporting | Chargé S, Young D | 2018 | Blood.ca website | View Adverse reactions reporting | Health care providers | Other |
Initial flow cytometric evaluation of the Clearllab lymphoid screen | Hedley BD, Cheng G, Luider J, Kern W, Lozanski G, Chin-Yee I, Lowes LE, Keeney M, Careaga D, Magari R, Tejidor L | 2018 | Cytometry B Clin Cytom | View Initial flow cytometric evaluation of the Clearllab lymphoid screen | Researchers | Basic research |
Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review | Kjaer M, Bertrand G, Bakchoul T, Massey E, Baker JM, Lieberman L, Tanael S, Greinacher A, Murphy MF, Arnold DM, Baidya S, Bussel J, Hume H, Kaplan C, Oepkes D, Ryan G, Savoia H, Shehata N, Kjeldsen-Kragh J, International Collaboration for Transfusion Medicine Guidelines | 2018 | Vox Sang | View Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review | Researchers | Clinical research |
Clinical Outcomes and Red Blood Cell Storage | Ning S, Heddle NM | 2018 | Hematologic Challenges in the Critically Ill | View Clinical Outcomes and Red Blood Cell Storage | Other | Other |
Les concentrés de facteurs de coagulation | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Guide de la pratique transfusionnelle | View Les concentrés de facteurs de coagulation | Health care providers | Other |
Hemostatic efficacy of pathogen-inactivated versus untreated platelets: a randomized controlled trial | van der Meer PF, Ypma PF, van Geloven N, van Hilten JA, van Wordragen-Vlaswinkel RJ, Eissen O, Zwaginga JJ, Trus M, Beckers EAM, te Boekhorst P, Tinmouth A, Lin Y, Hsia C, Lee D, Norris PJ, Goodrich RP, Brand A, Hervig T, Heddle NM, van der Bom JG, Kerkhoffs J-LH | 2018 | Blood | View Hemostatic efficacy of pathogen-inactivated versus untreated platelets: a randomized controlled trial | Researchers | Clinical research |
Routine screening method for microparticles in platelet transfusions | Millar D, Murphy L, Labrie A, Maurer-Spurej E | 2018 | J Vis Exp | View Routine screening method for microparticles in platelet transfusions | Health care providers | New or improved product or process |
Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score | Balitsky AK, Kelton JG, Arnold DM | 2018 | Blood | View Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score | Researchers | New or improved product or process |
Focusing in on use of pharmacokinetic profiles in routine hemophilia care | Croteau SE, Callaghan MU, Davis J, Dunn AL, Guerrera M, Khan O, Neufeld EJ, Raffini LJ, Recht M, Wang M, Iorio A | 2018 | Res Pract Thromb Haemost | View Focusing in on use of pharmacokinetic profiles in routine hemophilia care | Health care providers | Clinical research |
Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project | Iorio A, Skinner MW, Clearfield E, Messner D, Pierce GF, Witkop M, Tunis S | 2018 | Haemophilia | View Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project | Health care providers | Clinical research |
The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2 | Lemay A-S, Tong TN, Branch DR, Huang M, Sumner C, Oldfield L, Hawes J, Cserti-Gazdewich CM, Lau W | 2018 | Transfusion | View The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2 | Researchers | Clinical research |
Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial | Pai M, Adhikari NKJ, Ostermann M, Heels-Ansdell D, Douketis JD, Skrobik Y, Qushmaq I, Meade M, Guyatt G, Geerts W, Walsh MW, Crowther MA, Friedrich JO, Burry L, Bellomo R, Brandao da Silva N, Costa Filho R, Cox MJ, Alves Silva S, Cook DJ, on behalf of the PROTECT Investigators | 2018 | PLoS One | View Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial | Researchers | Clinical research |
Ultraviolet-based pathogen inactivation systems: untangling the molecular targets activated in platelets | Schubert P, Johnson L, Marks DC, Devine DV | 2018 | Front Med | View Ultraviolet-based pathogen inactivation systems: untangling the molecular targets activated in platelets | Researchers | Basic research |
Intravenous immune globulin to prevent heparin-induced thrombocytopenia | Warkentin TE, Climans TH, Morin P-A | 2018 | N Engl J Med | View Intravenous immune globulin to prevent heparin-induced thrombocytopenia | Health care providers | Other |
Blood and clots series: How can I tell whether this patient has a deep vein thrombosis? | de Wit K | 2018 | CanadiEM website | View Blood and clots series: How can I tell whether this patient has a deep vein thrombosis? | Health care providers | Benchmarking and standard setting |
Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers | Visram A, Bredeson C, Allan D, Sabloff M, Huebsch L, Tay J, Kekre N, McDiarmid S, Mallick R, Tinmouth A, Martin L, Hamelin L, Maze D | 2018 | Blood Cancer J | View Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers | Health care providers | Clinical research |
Assignment of cytomegalovirus infection status in infants awaiting solid organ transplant: Viral detection methods as adjuncts to serology | Burton CE, Dragan T, Mabilangan CA, O'Brien SF, Fearon M, Scalia V, Preiksaitis JK | 2018 | Pediatr Transplant | View Assignment of cytomegalovirus infection status in infants awaiting solid organ transplant: Viral detection methods as adjuncts to serology | Health care providers | Clinical research |
Improving Time to Antibiotics for Pediatric Oncology Patients With Fever and Suspected Neutropenia by Applying Lean Principles | Geerlinks AV, Digout C, Bernstein M, Chan A, MacPhee S, Pambrun C, Gallant G, Wyatt L, Fernandez CV, Price VE | 2018 | Pediatric Emergency Care | View Improving Time to Antibiotics for Pediatric Oncology Patients With Fever and Suspected Neutropenia by Applying Lean Principles | Researchers | New or improved product or process |
More than one way to enhance bacterial detection in platelet components | Kamel H, Goldman M | 2018 | Transfusion | View More than one way to enhance bacterial detection in platelet components | Other | New or improved product or process |